Specification of Treg cells: learning from FoxP3 deficiencies
Treg 细胞的规范:从 FoxP3 缺陷中学习
基本信息
- 批准号:10652618
- 负责人:
- 金额:$ 55.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-27 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalATAC-seqAffectAlanineAppearanceArchitectureAustraliaAutoimmuneAutoimmune DiseasesAutoimmunityBackBostonCD4 Positive T LymphocytesCell NucleusCell physiologyCellsCharacteristicsChromatinChromatin StructureClinicalClustered Regularly Interspaced Short Palindromic RepeatsColitisCollaborationsComplexControlled EnvironmentCytometryDataDefectDermatitisDiseaseEngineeringEnhancersEnvironmentFOXP3 geneFamilyFemaleFoundationsFunctional disorderGene ExpressionGene Expression ProfileGenesGeneticGenetic TranscriptionGenomicsGrantHeterozygoteHomeostasisHumanImmune ToleranceImmunologicsInflammationInternal Ribosome Entry SiteItalyLearningLesionLinkLocationLymphoidMapsMediatorMicrobeMissense MutationModelingMolecularMothersMusMutant Strains MiceMutationNuclearNuclear StructureOrganOrganismParis, FrancePathologyPatientsPhenotypePlayPredispositionProteinsRecording of previous eventsRegulationRegulatory T-LymphocyteReporterRepressionResolutionSamplingScanningSeveritiesSpecific qualifier valueStructureSymptomsT-LymphocyteTestingTissuesUnited States National Institutes of HealthVariantWorkclinically relevantcofactorconditioningforkhead proteinimmunopathologyimmunoregulationin vivoinsightmalemicrobialmultiple omicsmutantnovelpathobiontprogramspromoterresponsesingle-cell RNA sequencingsuperresolution microscopysymptomatologytranscription factortranscriptometranscriptome sequencingtranscriptomics
项目摘要
T regulatory (Treg) cells help maintain immunologic tolerance and control inflammation in many contexts. Their
dysfunction leads to multi-organ autoimmunity in FoxP3-deficient mice and human IPEX patients, with variable
clinical manifestations. Treg function and homeostasis are dependent on the transcription factor FoxP3,
encoded on ChrX, which determines a substantial portion of their specific transcriptome. Our prior work on
FoxP3 structure/function explored how FoxP3’s interactions with different cofactors within multimolecular
complexes that reside in different nuclear compartments, and condition its transactivating potential on different
transcriptional targets. Further, single-cell cytometry and transcriptomics of T cells from FOXP3-deficient
patients and mice revealed a narrow cell-intrinsic signature of the deficiency, directly controlled by FoxP3, and
a larger disease signature, conferred in a cell-extrinsic manner, that affects both Treg and conventional CD4+
T cells. We hypothesize that these components vary according to the actual FOXP3 lesion, mutations in
different interaction facets leading to different pathology, and that environmental and activation triggers
promote the unfolding of the full cell-extrinsic IPEX signature. In Aim1, to better understand the components of
Treg dysfunction in IPEX patients, we will analyze the impact of missense FOXP3 mutations by single-cell
RNAseq in CD4+ T cells from paired IPEX patients and carrier female relatives (typically mothers), in which we
distinguish Treg-like cells expressing wild-type or mutant FOXP3 through random ChrX-inactivation and SNP-
based cell identification. Effects on chromatin will also be mapped (ATACseq), and related back to
symptomatology in these patients. To enable further analysis in a genetically and environmentally controlled
environment, where sample access is not limiting, Aim2 uses CRISPR editing to introduce eight selected
missense FOXP3 mutations from IPEX patients into B6 mice, where lymphoid and tissue-resident Tregs will be
examined and profiled. Super-resolution microscopy and HiChIPseq will assess the effect of the FOXP3
mutations on localization of the mutant proteins in the nucleus, in terms of nuclear structure and enhancer-
promoter loops. We will also analyze the timing and determinants of acquisition of the dominant Treg-extrinsic
signature. Aim3 will use this FoxP3 mutant mouse panel to ask how mutation-specific transcriptional features
relate to the IPEX-relevant clinical characteristics in mice: appearance of spontaneous autoimmunity (scurfy-
like disease), susceptibility to induced autoimmunity (colitis, dermatitis). Challenges with defined microbes and
microbial molecules will test the hypothesis that clinical variability in IPEX results, at least in part, from
environmental and infectious triggers. These interconnected Aims, with complementary explorations on mice
and humans, will bring unique information on how variation in a transcription factor modulates its ability to
influence gene expression through chromatin and genomic 3D architecture, and how these relate to a
monogenic loss of tolerance in human patients.
调节性T细胞(Treg)在许多情况下有助于维持免疫耐受和控制炎症。他们的
功能障碍导致FoxP 3缺陷小鼠和人IPEX患者的多器官自身免疫,
临床表现Treg的功能和稳态依赖于转录因子FoxP 3,
在ChrX上编码,这决定了它们特定转录组的大部分。我们之前的工作
FoxP 3的结构/功能探讨了FoxP 3如何与多分子内的不同辅因子相互作用。
复合物驻留在不同的核隔室,并在不同的条件下,其反式激活潜力
转录靶点。此外,来自FOXP 3缺陷型的T细胞的单细胞细胞计量术和转录组学研究显示,
患者和小鼠显示出由FoxP 3直接控制的狭窄的细胞内在缺陷特征,
以细胞外在方式赋予的更大的疾病特征,其影响Treg和常规CD 4 +
T细胞。我们假设这些成分根据实际FOXP 3病变而变化,
不同的相互作用方面导致不同的病理,环境和激活触发
促进全细胞外在IPEX签名的解折叠。在目标1中,为了更好地理解
IPEX患者的Treg功能障碍,我们将通过单细胞免疫组化分析错义FOXP 3突变的影响。
来自配对IPEX患者和携带者女性亲属(通常是母亲)的CD 4 + T细胞中的RNAseq,其中我们
通过随机ChrX失活和SNP-1区分表达野生型或突变型FOXP 3的Treg样细胞。
基于细胞识别。对染色质的影响也将被映射(ATACseq),并与
在这些患者中,为了能够在基因和环境控制下进行进一步分析,
环境中,在样本访问不受限制的情况下,Aim 2使用CRISPR编辑来引入八个选定的
将IPEX患者的错义FOXP 3突变导入B6小鼠,其中淋巴和组织驻留型THBG将被
检查和分析。超分辨率显微镜和HiChIPseq将评估FOXP 3
突变对突变蛋白在细胞核中的定位,就细胞核结构和增强子而言,
启动子环我们还将分析获得显性Treg-外源性的时机和决定因素,
签名. Aim 3将使用这个FoxP 3突变小鼠小组来询问突变特异性转录特征如何影响基因表达。
与小鼠中IPEX相关的临床特征有关:自发性自身免疫的出现(皮屑-
类似疾病),对诱导的自身免疫的易感性(结肠炎、皮炎)。确定的微生物的挑战,
微生物分子将测试IPEX结果的临床变异性的假设,至少部分来自
环境和传染诱因这些相互关联的目标,以及对小鼠的互补探索
和人类,将带来独特的信息,如何在转录因子的变化调节其能力,
通过染色质和基因组3D结构影响基因表达,以及这些如何与
人类患者的单基因耐受性丧失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHE O. BENOIST其他文献
CHRISTOPHE O. BENOIST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHE O. BENOIST', 18)}}的其他基金
Specification of Treg cells: learning from FoxP3 deficiencies
Treg 细胞的规范:从 FoxP3 缺陷中学习
- 批准号:
10521755 - 财政年份:2022
- 资助金额:
$ 55.6万 - 项目类别:
T regulatory cell subsets at the microbial interface: determinism and function
微生物界面的 T 调节细胞亚群:决定论和功能
- 批准号:
9892948 - 财政年份:2017
- 资助金额:
$ 55.6万 - 项目类别:
Specification of Treg cells: FOXP3 functional facets
Treg 细胞的规格:FOXP3 功能方面
- 批准号:
9038990 - 财政年份:2015
- 资助金额:
$ 55.6万 - 项目类别:
Specification of Treg cells: FOXP3 functional facets
Treg 细胞的规格:FOXP3 功能方面
- 批准号:
8863338 - 财政年份:2015
- 资助金额:
$ 55.6万 - 项目类别:
Specification of Treg cells: FOXP3 functional facets
Treg 细胞的规格:FOXP3 功能方面
- 批准号:
9461146 - 财政年份:2015
- 资助金额:
$ 55.6万 - 项目类别:
Gut microbiome influences on autoimmune disease
肠道微生物组对自身免疫性疾病的影响
- 批准号:
8882581 - 财政年份:2014
- 资助金额:
$ 55.6万 - 项目类别:
Gene Expression and Regulatory Networks in Human Leukocytes
人类白细胞的基因表达和调控网络
- 批准号:
7854791 - 财政年份:2009
- 资助金额:
$ 55.6万 - 项目类别:
Gene Expression and Regulatory Networks in Human Leukocytes
人类白细胞的基因表达和调控网络
- 批准号:
7945283 - 财政年份:2009
- 资助金额:
$ 55.6万 - 项目类别:
相似国自然基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
- 批准号:81802809
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
- 批准号:31802046
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
- 批准号:31801915
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
- 批准号:31871331
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
- 批准号:
10806548 - 财政年份:2023
- 资助金额:
$ 55.6万 - 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
- 批准号:
10210424 - 财政年份:2018
- 资助金额:
$ 55.6万 - 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
- 批准号:
1714070 - 财政年份:2017
- 资助金额:
$ 55.6万 - 项目类别:
Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
- 批准号:
10558379 - 财政年份:2001
- 资助金额:
$ 55.6万 - 项目类别:














{{item.name}}会员




